Your Immune System Is Attacking Your Thyroid. Your Genes May Be Why.

HLA-DQ2 is part of your major histocompatibility complex, the system your immune cells use to decide what counts as self and what counts as foreign. Think of it as the display screen your antigen-presenting cells show to your T-cells. If a protein looks dangerous on that screen, your T-cells attack it. If it looks safe, they leave it alone.

Carrying HLA-DQ2 fundamentally changes this display. Roughly 25 to 30 percent of people with European ancestry carry HLA-DQ2. When you do, your antigen-presenting cells are more likely to display thyroid peroxidase (TPO), thyroglobulin (Tg), and other thyroid proteins as foreign threats. Your immune system isn’t being overly aggressive; it’s being shown thyroid proteins as enemies by design. This is why HLA-DQ2 is required for celiac disease susceptibility and strongly associated with type 1 diabetes and other autoimmune conditions.

In lived experience, this means your immune system needs a lower provocation threshold to attack your thyroid. A viral infection that might trigger a brief immune response in someone without HLA-DQ2 can lock in a permanent autoimmune response in you. Your immune system remembers thyroid proteins as enemies and stays vigilant against them forever.

CTLA4 is a brake pedal on your T-cell response. Once your immune system identifies a threat (like a viral infection or, in autoimmunity, a mistaken identity of thyroid protein as foreign), your T-cells activate and multiply. CTLA4 is what stops this process before it spirals into chronic attack. It delivers a signal that says: enough is enough, stand down.

The CTLA4 +49A>G variant reduces this braking function. Roughly 45 percent of people carry the G allele. When you do, your T-cells stay activated longer and proliferate more aggressively before receiving the stop signal. This means once your immune system locks onto thyroid tissue as a target, it keeps attacking instead of self-limiting. The attack becomes chronic autoimmunity instead of a brief immune response.

The lived experience is a thyroid attack that doesn’t resolve on its own. You develop high TPO antibodies that stay elevated for years. Even when you’re doing everything right, even when stress is low and infections are rare, the antibodies remain. This is CTLA4 failing to put the brakes on.

TNF-alpha is one of the most potent pro-inflammatory cytokines your body produces. It amplifies immune signaling, increases vascular permeability, and drives systemic inflammation. In small doses during an acute infection, TNF-alpha is helpful. In chronic overproduction, it fuels autoimmune disease.

The TNF -308G>A variant increases baseline TNF-alpha production. Roughly 30 percent of people carry the A allele. If you do, your baseline inflammatory state is elevated even when you’re not actively fighting an infection. This means your thyroid is bathed in higher levels of inflammatory signals, making it more likely to be targeted by immune cells and more likely for the attack to intensify once it begins.

You may notice this as persistent joint aches, elevated inflammatory markers on bloodwork, or a thyroid attack that seems out of proportion to any obvious trigger. Your inflammation isn’t just responding to current stressors; it’s constitutionally higher because of how your TNF-alpha gene is wired.

IL-6 is an inflammatory cytokine that amplifies immune signaling beyond just the thyroid. Once immune cells in your thyroid start producing IL-6, it broadcasts an inflammatory signal systemically, recruiting more immune cells and amplifying the attack. IL-6 also crosses the blood-brain barrier easily, making it a key driver of neuroinflammation and brain fog.

The IL6 -174G>C variant shifts your set point for IL-6 production upward. Roughly 40 percent of people carry the C allele. When you do, your cells produce more IL-6 in response to immune activation, which amplifies the inflammatory cascade and spreads it throughout your body. This is why IL-6 variants are associated not just with thyroid autoimmunity but with systemic inflammation, depression, and cognitive decline.

The lived experience is thyroid autoimmunity that doesn’t stay localized. You develop antibodies against your thyroid, but you also develop widespread inflammation: joint pain, brain fog, fatigue that feels systemic rather than thyroid-specific. Your inflammation spreads.

PTPN22 encodes lymphoid tyrosine phosphatase, an enzyme critical for regulatory T-cell function. Regulatory T-cells (Tregs) are the peacekeepers of your immune system. They suppress excessive immune activation and maintain tolerance to self-antigens like your thyroid. When PTPN22 function is reduced, Tregs don’t work properly, and tolerance breaks down.

The PTPN22 1858C>T variant, found in roughly 15 to 20 percent of people with European ancestry, reduces PTPN22 function specifically in Tregs. Your immune system loses its ability to rein in attacks once they start. Without effective Tregs, even a small thyroid-specific immune response can escalate into chronic autoimmunity. This variant is strongly associated with type 1 diabetes, rheumatoid arthritis, and other autoimmune conditions.

The lived experience is autoimmunity that develops after an infection or major stressor and then doesn’t resolve. Your immune system was supposed to stand down after the threat passed. Instead, it stayed activated. Your Tregs failed to put the brakes on.

IRF5 (interferon regulatory factor 5) is a master regulator of innate immune responses. When your immune system detects a viral infection or other threat, IRF5 amplifies the interferon response, which triggers adaptive immunity (antibody production, T-cell activation). IRF5 essentially turns up the volume on your antiviral defenses.

IRF5 variants associated with autoimmunity increase the baseline activation of this pathway. Roughly 10 to 15 percent of people of European ancestry carry the high-risk variants. When you do, your innate immune response to viral infections is hyperactive, and this hyperactivity can cross-react with thyroid antigens. A viral infection that would trigger a normal immune response in someone else can lock in a permanent autoimmune response in you because your IRF5 gene amplifies the signal too much.

The lived experience often includes a clear trigger: your thyroid autoimmunity began after a specific viral infection (often EBV, COVID-19, or another herpesvirus). Your immune system was supposed to clear the virus and move on. Instead, it got stuck in overdrive and began attacking thyroid tissue that resembled viral proteins.